Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | QPCT | Q16769 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23787514 | 0.98 | NFKB1 (0.37) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL17128637 | 0.77 | NFKB1 (0.36) | NFKB1QPCTHSD17B10QPCTL | |
| SCHEMBL217284 | 0.74 | — | — | |
| SCHEMBL10503985 | 0.74 | NFKB1 (0.46) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| Bromide SCHEMBL28508208 | 0.72 | NFKB1 (0.43) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL887474 | 0.69 | — | — | |
| SCHEMBL12020402 | 0.68 | NFKB1 (0.43) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL918948 | 0.67 | NFKB1 (0.39) | NFKB1QPCTHSD17B10QPCTLCYP17A1 | |
| SCHEMBL21461069 | 0.67 | NFKB1 (0.39) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL918580 | 0.67 | NFKB1 (0.39) | NFKB1QPCTHSD17B10QPCTLTBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025104679-A1 | PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-22 | — | — | WO | claimed |
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | claimed |
| CN-115458809-A | Electrolyte and lithium ion battery comprising same | 香河昆仑新能源材料股份有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-113258138-B | Full-inorganic salt type rechargeable magnesium battery electrolyte and preparation method thereof | 重庆大学 | 2022-10-21 | — | — | CN | claimed |
| CN-113258138-A | Full-inorganic salt type rechargeable magnesium battery electrolyte and preparation method thereof | 重庆大学 | 2021-08-13 | — | — | CN | claimed |
| US-11085939-B2 | Quantifying phosphatidylethanol from blood samples | LOYOLA UNIVERSITY OF CHICAGO (US) | 2021-08-10 | — | — | US | claimed |
| CN-111900477-A | High-voltage lithium ion battery electrolyte film-forming additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-11-06 | — | — | CN | claimed |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY | 2020-06-04 | — | — | US | claimed |
| CN-111100054-A | α' -dihydroxy-diisopropylbenzene, bis- (tert-butylperoxyisopropyl) benzene and epoxy compound synthesis method | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| US-20190293668-A1 | QUANTIFYING PHOSPHATIDYLETHANOL FROM BLOOD SAMPLES | LOYOLA UNIVERSITY OF CHICAGO | 2019-09-26 | — | — | US | claimed |
| US-20030125593-A1 | Catalyst composition and processes therefor and therewith | PHILLIPS PETROLEUM COMPANY | 2003-07-03 | — | — | US | claimed |
| US-6509289-B1 | Comprises an alumina, a metal oxide, a phosphorus oxide and optionally, an acid site modifier | PHILLIPS PETROLEUM COMPANY | 2003-01-21 | — | — | US | claimed |
| WO-2002048113-A1 | CYCLIZATION PROCESS STEP IN THE MAKING OF QUINOLONES AND NAPHTHYRIDINES | THE PROCTER & GAMBLE COMPANY (US) | 2002-06-20 | — | — | WO | claimed |
| US-6365643-B1 | Photoinitiators for cationic curing | TH. GOLDSCHMIDT AG (DE) | 2002-04-02 | — | — | US | claimed |
| US-20020016258-A1 | CATALYST COMPOSITION AND PROCESSES THEREFOR AND THEREWITH | PHILLIPS PETROLEUM COMPANY (OK) | 2002-02-07 | — | — | US | claimed |
| US-6051519-A | MODIFIED ZEOLITE ZSM-5 | PHILLIPS PETROLEUM COMPANY (US) | 2000-04-18 | — | — | US | claimed |
| US-6037302-A | USING CATALYST COMPRISING ALUMINA, METAL OXIDE, PHOSPHORUS OXIDE AND OPTIONALLY, AN ACID SITE MODIFIER SELECTED FROM THE GROUP CONSISTING OF SILICON OXIDES, SULFUR OXIDES, BORON OXIDES, MAGNESIUM OXIDES, TIN OXIDES, TITANIUM OXIDES, | PHILLIPS PETROLEUM COMPANY (US) | 2000-03-14 | — | — | US | claimed |
| US-5877379-A | CALCINED ZEOLITE/BINDER IMPREGNATED WITH SILICON OXIDES OR PHOSPHORUS OXIDES | PHILLIPS PETROLEUM COMPANY (US) | 1999-03-02 | — | — | US | claimed |
| US-5763721-A | CATALYST COMPRISED OF METAL OXIDE PROMOTED ALUMINA CONTAINING A SILICON OXIDE AND PHOSPHORUS OXIDE | PHILLIPS PETROLEUM COMPANY (US) | 1998-06-09 | — | — | US | claimed |
| US-5714660-A | HYDRODEALKYLATION OF AROMATIC HYDROCARBONS TO AROMATICS HAVING 6-8 CARBONS USING METAL OXIDE/ALUMINA SUPPORTED CATALYSTS IMPREGNATED WITH SILICA OR PHOSPHORUS OXIDE; ANTIDEPOSIT AGENTS, BY-PRODUCT INHIBITION | PHILLIPS PETROLEUM COMPANY (US) | 1998-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | MLX, LDHA, CA2 | NFKB1 4761/4885QPCT 1318/4885HSD17B10 299/4885 |
| US-20200171474-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | MLX, LDHA, CA2 | NFKB1 4761/4885QPCT 1318/4885HSD17B10 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.